George Church (courtesy EnPlusOne BioSciences)
George Church, Wyss scientists and Northpond challenge conventional RNA manufacturing with new biotech
RNA medicine has been at the forefront for the past few years, with the first RNA silencing therapy approved in 2018, and mRNA Covid vaccines …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
